Adenosine stress perfusion cardiac magnetic resonance imaging in patients undergoing intracoronary bone marrow cell transfer after ST-elevation myocardial infarction: the BOOST-2 perfusion substudy.
Andreas SeitzKai C WollertGerd P MeyerJochen Müller-EhmsenCarsten TschöpeAndreas E MayKlaus EmpenEmmanuel ChorianopoulosBenedikta RitterJens PirrLubomir ArsenievHans-Gert HeuftArnold GanserEed Abu-ZaidHugo A KatusStephan B FelixMeinrad P GawazHeinz-Peter SchultheissDennis LadageJohann BauersachsHeiko MahrholdtSimon GreulichPublished in: Clinical research in cardiology : official journal of the German Cardiac Society (2019)
Infarct perfusion improves from baseline to 6 months and predicts LVEF recovery in STEMI patients undergoing early PCI. Intracoronary BMC therapy did not enhance infarct perfusion in the BOOST-2 trial.
Keyphrases
- st elevation myocardial infarction
- percutaneous coronary intervention
- patients undergoing
- acute myocardial infarction
- contrast enhanced
- bone marrow
- st segment elevation myocardial infarction
- acute coronary syndrome
- antiplatelet therapy
- coronary artery disease
- coronary artery bypass grafting
- clinical trial
- single cell
- computed tomography
- magnetic resonance imaging
- left ventricular
- atrial fibrillation
- cell therapy
- open label
- double blind
- chemotherapy induced